Akao Makoto, Hasebe Yuichi, Okumura Nobuaki, Hagiwara Hiromi, Seki Taiichiro, Ariga Toyohiko
Department of Nutrition and Physiology, Nihon University Graduate School of Applied Life Sciences, Kameino 1866, Fujisawa, Kanagawa 252-8510, Japan.
Thromb Res. 2002 Aug 15;107(3-4):169-74. doi: 10.1016/s0049-3848(02)00258-x.
BACKGROUND/AIMS: Liver regeneration after partial hepatectomy is thought to be regulated by various molecules including the components of the plasminogen activator (PA)-plasmin system. We have examined the role of fibrinolytic factors, i.e., tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA), and their substrate, plasminogen, in the proliferation of hepatocytes in primary culture.
Hepatocyte and nonparenchymal liver cells were isolated from Wistar strain rat by a method perfusing the liver with collagenase. DNA synthesis was assessed by measuring the incorporation of [3H]-thymidine into cellular DNA fraction. tPA, uPA and type-1 plasminogen activator inhibitor (PAI-1) gene expressions were measured by Northern blotting. PA activity was measured by fibrin/agarose plate method.
Cellular density-dependent DNA synthesis was observed in the primary cultured hepatocytes; DNA synthesis was lower at high cell density (1.0 x 10(5) cells/cm(2)) than that at low cell density (0.2 x 10(5) cells/cm(2)). DNA synthesis in the hepatocytes cultured at a low cell density was increased by co-culture with nonparenchymal liver cells. Under these growth-stimulated culture conditions, tPA and uPA mRNAs were induced and up-regulated. On the contrary, the PAI-1 mRNA level was decreased under these conditions, and total PA activity was augmented accordingly. The synthetic plasmin inhibitor tranexamic acid, a competitive inhibitor for the plasmin molecule, and PASI-535, a plasmin active center-directed inhibitor, both suppressed hepatocyte proliferation in a dose-dependent fashion. Anti-plasmin antibody also suppressed hepatocyte proliferation.
The up-regulation of PA activity for ensuring plasmin activity should be an important mechanism in the proliferation of hepatocytes.
背景/目的:部分肝切除术后的肝再生被认为受多种分子调控,包括纤溶酶原激活物(PA)-纤溶酶系统的成分。我们研究了纤溶因子,即组织型纤溶酶原激活物(tPA)和尿激酶型纤溶酶原激活物(uPA)及其底物纤溶酶原在原代培养肝细胞增殖中的作用。
采用胶原酶灌注肝脏的方法从Wistar品系大鼠分离肝细胞和非实质肝细胞。通过测量[3H]-胸苷掺入细胞DNA组分来评估DNA合成。通过Northern印迹法测量tPA、uPA和1型纤溶酶原激活物抑制剂(PAI-1)基因表达。通过纤维蛋白/琼脂糖平板法测量PA活性。
在原代培养的肝细胞中观察到细胞密度依赖性DNA合成;高细胞密度(1.0×10⁵个细胞/cm²)时的DNA合成低于低细胞密度(0.2×10⁵个细胞/cm²)时。低细胞密度培养的肝细胞与非实质肝细胞共培养时,DNA合成增加。在这些生长刺激的培养条件下,tPA和uPA mRNA被诱导并上调。相反,在此条件下PAI-1 mRNA水平降低,总PA活性相应增加。合成纤溶酶抑制剂氨甲环酸(一种纤溶酶分子的竞争性抑制剂)和PASI-535(一种纤溶酶活性中心导向抑制剂)均以剂量依赖性方式抑制肝细胞增殖。抗纤溶酶抗体也抑制肝细胞增殖。
确保纤溶酶活性的PA活性上调应是肝细胞增殖的重要机制。